Full history for every metric is available with a Kvantra account
CLS Holdings USA, Inc. (CLSH)
Key financial summary
Financials in USD| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 8 | 12 | 19 | 23 | 23 | 20 | 18 |
| Operating profit | $m | -2 | -2 | |||||
| Net profit | $m | -28 | -34 | -16 | -2 | -14 | -4 | - |
| EPS reported | $ | -0.05 | - | |||||
| Operating cashflow per share | $ | 0.01 | 0.01 | |||||
| Capex per share | $ | 0.00 | 0.00 | |||||
| FCF per share | $ | 0.01 | 0.01 | |||||
| Free cash flow | $m | 1 | 0 | |||||
| Net debt | $m | 6 | 3 | |||||
| Book value equity | $m | -12 | -11 | |||||
| Book value per share | $ | -0.12 | -0.07 | |||||
| Number of shares | m | 98.86 | 164.73 | |||||
| DPS (TTM paid) | $ | 0.00 | 0.00 |
Financial summary
Financials in USD| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | - | - | |||||
| P/B LTM | x | -0.42 | -0.52 | |||||
| P/S LTM | x | 0.25 | 0.34 | |||||
| P/FCF LTM | x | 7.48 | 481.61 | |||||
| EV/EBITDA LTM | x | 33.07 | 1.84 | |||||
| EV/Sales LTM | x | 0.65 | 0.51 | |||||
| Earnings Yield LTM | % | -90.79% | -125.92% | |||||
| FCF Yield | % | 13.36% | 0.21% | |||||
| Quality | ||||||||
| ROE | % | 38.13% | 36.74% | |||||
| ROIC | % | 46.07% | 46.07% | |||||
| Operating margin | % | -10.00% | -10.00% | |||||
| Gross margin | % | 42.68% | 42.68% | |||||
| FCF/Sales | % | 3.31% | 3.31% | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | - | - | |||||
| Sales Growth YoY | % | -13.71% | +11.74% | |||||
| Net Income Growth YoY | % | - | - | |||||
| FCF Growth | % | - | -99.02% | |||||
| Operating Profit Growth | % | - | - | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | 0.00% | 0.00% | |||||
| Dividend Growth | % | 0.00% | 0.00% | |||||
| Payout Ratio | % | 0.00% | 0.00% | |||||
| FCF/Debt | x | 0.08 | 0.00 | |||||
| Net Debt/EBITDA | x | 20.42 | 20.42 | |||||
| EBIT/Net interest | x | -1.05 | -1.05 | |||||
| Net debt/market cap | % | 121.70% | 49.40% | |||||
| Net debt/Equity | x | -0.51 | -0.26 | |||||
| Gross debt/equity | x | -0.73 | -0.42 | |||||
Company overview
CLS Holdings USA, Inc., a diversified cannabis enterprise established in 2014 and headquartered in Miami, Florida, focuses its operations in the United States on extracting and transforming cannabinoids. The company specializes in isolating cannabinoids from cannabis plants and converting them into a variety of concentrates, including oils, waxes, edibles, and shatters. Its comprehensive service and product portfolio includes: Supplying organic medical cannabis to licensed retailers. Providing recreational marijuana products to authorized distributors and retailers. Offering its own in-house derived extraction products, such as oils and waxes. Delivering specialized processing and extraction services for licensed medical cannabis cultivators. Distributing cannabis strains in the form of vegetative cuttings to licensed medical cannabis growers. Providing consulting expertise to various cannabis-related businesses, including cultivators, dispensaries, and laboratories. Performing toll processing services. The company markets its products under the well-known Oasis Cannabis and City Trees brand names, with its concentrates serving pharmaceutical and other purposes.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
CLS Holdings USA, Inc. (CLSH)
CLS Holdings USA, Inc., a diversified cannabis enterprise established in 2014 and headquartered in Miami, Florida, focuses its operations in the United States on extracting and transforming cannabinoids. The company specializes in isolating cannabinoids from cannabis plants and converting them into a variety of concentrates, including oils, waxes, edibles, and shatters. Its comprehensive service and product portfolio includes: Supplying organic medical cannabis to licensed retailers. Providing recreational marijuana products to authorized distributors and retailers. Offering its own in-house derived extraction products, such as oils and waxes. Delivering specialized processing and extraction services for licensed medical cannabis cultivators. Distributing cannabis strains in the form of vegetative cuttings to licensed medical cannabis growers. Providing consulting expertise to various cannabis-related businesses, including cultivators, dispensaries, and laboratories. Performing toll processing services. The company markets its products under the well-known Oasis Cannabis and City Trees brand names, with its concentrates serving pharmaceutical and other purposes.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free